Oppenheimer raised the firm’s price target on Hamilton Lane (HLNE) to $230 from $220 and keeps an Outperform rating on the shares. The firm notes Hamilton Lane had a strong Q3 and the stock initially opened up 3% before ultimately selling-off by market close as the Alts sector was further pressured by credit concerns that Oppenheimer views as misguided.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLNE:
